Flutiform 50 µg - 5 µg press. inhal. susp. press. cont. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

flutiform 50 µg - 5 µg press. inhal. susp. press. cont.

mundipharma bv-srl - fluticasone propionate 0,05 mg; sodium cromoglicate 0,024 mg; formoterol fumarate dihydrate 0,005 mg - pressurised inhalation, suspension - 50 µg - 5 µg - fluticasone propionate 0.05 mg; formoterol fumarate dihydrate 5 µg - formoterol and fluticasone

Flutiform 125 µg - 5 µg press. inhal. susp. press. cont. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

flutiform 125 µg - 5 µg press. inhal. susp. press. cont.

mundipharma bv-srl - fluticasone propionate 0,125 mg; sodium cromoglicate 0,024 mg; formoterol fumarate dihydrate 0,005 mg - pressurised inhalation, suspension - 125 µg - 5 µg - fluticasone propionate 125 µg; formoterol fumarate dihydrate 5 µg - formoterol and fluticasone

Flutiform 250 µg - 10 µg press. inhal. susp. press. cont. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

flutiform 250 µg - 10 µg press. inhal. susp. press. cont.

mundipharma bv-srl - formoterol fumarate dihydrate 0,01 mg; fluticasone propionate 0,25 mg - pressurised inhalation, suspension - 250 µg - 10 µg - fluticasone propionate 0.25 mg; formoterol fumarate dihydrate 0.01 mg - formoterol and fluticasone

Flutiform K-haler 125 µg/dose - 5 µg/dose press. inhal. susp. inhaler Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

flutiform k-haler 125 µg/dose - 5 µg/dose press. inhal. susp. inhaler

mundipharma bv-srl - fluticasone propionate 0,125 mg/dose; formoterol fumarate dihydrate 0,005 mg/dose - pressurised inhalation, suspension - 125 µg/dose - 5 µg/dose - fluticasone propionate 0.125 mg/dose; formoterol fumarate dihydrate 0.005 mg/dose - formoterol and fluticasone

Flutiform K-haler 50 µg/dose - 5 µg/dose press. inhal. susp. inhaler Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

flutiform k-haler 50 µg/dose - 5 µg/dose press. inhal. susp. inhaler

mundipharma bv-srl - fluticasone propionate 0,05 mg/dose; formoterol fumarate dihydrate 0,005 mg/dose - pressurised inhalation, suspension - 50 µg/dose - 5 µg/dose - fluticasone propionate 0.05 mg/dose; formoterol fumarate dihydrate 0.005 mg/dose - formoterol and fluticasone

TRIMBOW Israel - English - Ministry of Health

trimbow

kamada ltd, israel - beclometasone dipropionate; formoterol fumarate dihydrate; glycopyrronium as bromide - pressurised solution - glycopyrronium as bromide 9 mcg/delivered dose; formoterol fumarate dihydrate 5.2 mcg/delivered dose; beclometasone dipropionate 87.4 mcg/delivered dose - formoterol, glycopyrronium bromide and beclometasone - copd maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist. asthma maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.…

Fostair 200micrograms/dose / 6micrograms/dose inhaler United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

fostair 200micrograms/dose / 6micrograms/dose inhaler

chiesi ltd - formoterol fumarate dihydrate; beclometasone dipropionate - pressurised inhalation - 6microgram ; 200microgram

Bufomix Easyhaler, 160 micrograms/4.5 micrograms/inhalation, inhalation powder Malta - English - Medicines Authority

bufomix easyhaler, 160 micrograms/4.5 micrograms/inhalation, inhalation powder

orion corporation orionintie 1, fi-02200 espoo, finland - formoterol fumarate, dihydrate, budesonide - inhalation powder - formoterol fumarate dihydrate 4.5 µg budesonide 160 µg - drugs for obstructive airway diseases

FOSTER 2006 Israel - English - Ministry of Health

foster 2006

kamada ltd, israel - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - pressurised solution - formoterol fumarate dihydrate 6 mcg/actuation; beclometasone dipropionate anhydrous 200 mcg/actuation - formoterol and beclometasone - foster 200/6 is indicated in the regular treatment of asthma in adults where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate:- patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled rapid-acting beta2-agonist or- patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists.